For World Alzheimer’s Day, we look at the link between heart health, metabolic health and dementia risk – including the factors you may be able to change.
Reviewer: Ami Hansen (Head of Patient Care, RN)
Dementia is one of our biggest health fears, and much of it can feel beyond our control. Age and genes both play a part, and we cannot change either of them.
But there is a more hopeful side that gets far less attention. A significant proportion of dementia risk is linked to factors that may be changed. Several of these are also closely connected to your weight, heart health and wider metabolic health.
For World Alzheimer’s Day, here is the link explained plainly.
Nearly half of dementia risk may be modifiable
The key reference is the 2024 Lancet Commission on dementia. It concluded that around 45% of dementia cases are linked to 14 potentially modifiable risk factors. In other words, these are factors that may, in theory, be changed or managed.
Several are closely connected to weight and metabolic health. They include type 2 diabetes, obesity, high blood pressure, high cholesterol, physical inactivity, smoking and excess alcohol.
This is not about certainty. No one can promise that you will or will not develop dementia. It is about reducing the likelihood, and there are meaningful steps you can take.
Why weight and metabolic health matter for brain health
Your brain relies on healthy blood vessels and steady blood sugar. Raised blood pressure, high blood sugar and inflammation can gradually damage the heart and arteries. These same processes can also affect the small blood vessels that supply the brain.
That is why the simplest way to put it still holds true:
Midlife, usually considered to be your fourties to sixties, appears to be an especially important time. Carrying excess weight, living with type 2 diabetes or having high blood pressure during these years is associated with a higher risk of dementia later in life.
The Lancet Commission links diabetes with roughly a 70% higher risk and obesity with around a 30% higher risk. You can read more about the relationship between blood pressure and your weight.
What do GLP-1 medicines mean for dementia risk?
You may have seen headlines suggesting that weight-management medicines could help to protect the brain. The evidence needs to be viewed carefully.
Observational studies involving people living with diabetes or obesity have linked GLP-1 medicines with a lower risk of dementia. However, observational studies can show an association; they cannot prove that the medicine itself caused the lower risk.
Recent large phase 3 trials tested oral semaglutide in people who already had early Alzheimer’s disease. The treatment did not slow the progression of the disease.
This means any possible benefit may lie in reducing risk earlier in life, partly through improved metabolic health, rather than treating dementia once it has developed. It remains an important area of research, but it is not a reason to take a GLP-1 medicine specifically for brain health.
How to support brain health and reduce dementia risk
The encouraging part is that many of the steps that support your brain also support your heart. You do not need to follow a completely separate checklist.
- Look after your weight and metabolic health, including your blood pressure, blood sugar and cholesterol.
- Move regularly and eat a balanced diet. A Mediterranean-style eating pattern is among the best studied for brain health.
- Do not smoke, and keep alcohol intake low.
- Protect your sleep, and stay socially and mentally active.
- Look after your hearing, as untreated hearing loss is one of the larger modifiable risk factors for dementia.
It is never too early, or too late
Taking action in midlife appears to be particularly important, but the opportunity does not disappear as you get older. Positive changes can help at any age.
This is about lowering risk, rather than guaranteeing an outcome. Every improvement counts. Small, steady changes to your weight and metabolic health can support your brain while benefiting your heart at the same time.
How Envigore can help
We do not diagnose or treat dementia. That requires specialist care.
However, if you would like support with your weight, blood sugar or wider metabolic health, that is exactly where we can help. These are also important, modifiable parts of the wider brain-health picture.
Book a consultation with Envigore to explore the support available to you.
Frequently asked questions
These questions reflect the guidance above and are reviewed by our clinical team before publication.
You may be able to lower your risk, although there are no guarantees. The 2024 Lancet Commission links around 45% of dementia cases to potentially modifiable risk factors. Several relate to weight, blood pressure, blood sugar and physical activity. Addressing these factors, particularly in midlife, may help to reduce your risk.
Being overweight is associated with a higher risk of dementia, particularly when excess weight is carried in midlife. The Lancet Commission links obesity with an approximately 30% higher risk.
Weight also rarely acts alone. It can be linked with high blood pressure, high blood sugar and high cholesterol, which may affect the blood vessels that supply the brain.
The evidence is mixed and still developing. Observational studies have linked GLP-1 medicines with a lower risk of dementia in people living with diabetes or obesity. However, recent trials of oral semaglutide in people who already had early Alzheimer’s disease did not slow its progression.
Any potential benefit may therefore relate to improving metabolic health and reducing risk earlier in life, rather than treating Alzheimer’s disease. GLP-1 medicines are not a treatment for the brain.
No. Midlife appears to be an important time for dementia prevention, but changes can help at any age. Improving your weight, blood pressure and blood sugar can support your heart and your brain, whatever your age.
There is no single step that can prevent dementia. Looking after your heart is one of the most useful places to start because what protects your blood vessels also helps to protect your brain.
Aim to maintain a healthy weight, manage your blood pressure and blood sugar, move regularly, avoid smoking, and stay mentally and socially active.
+ Sources
- Livingston, G., et al. (2024). Dementia prevention, intervention and care: 2024 report of the Lancet Standing Commission. The Lancet, 404(10452), pp. 572–628.
- Cummings, J.L., et al. (2026). Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer’s disease (EVOKE and EVOKE+): two phase 3, randomised, placebo-controlled trials. The Lancet, 407(10544), pp. 2167–2179. https://doi.org/10.1016/S0140-6736(26)00459-9.
- Real-world and observational studies linking GLP-1 receptor agonists with lower dementia risk in people with type 2 diabetes and obesity (JAMA Network Open, 2025; Alzheimer’s & Dementia, 2024).
- Evidence on vascular disease, inflammation and metabolic risk factors in the development of dementia and Alzheimer’s disease.
About Your Clinical Team
This content was medically reviewed and approved by Danny Gian Hou Chu, a HCPC-Registered Advance Paramedic Prescriber (PA38670), who oversees all prescribing decisions at Envigore.
All prescriptions are dispensed by Right Medicine Pharmacy, a GPhC-Registered Pharmacy (No. 9012382).
Nutritional guidance and lifestyle support is provided by Veronica Giudice, a HCPC-Registered Dietitian (DT26570) and British Dietetic Association member.
Last medically reviewed: September 2026